Facebook
X
LinkedIn
ForwardFundamentals of Anticancer Therapy Day 1 - Enduring Material - Credit offering period - June 26, 2026 - December 31, 2026
Overview of Anticancer Therapies
Mary E. Kern, MSN, RN, OCN, CHSE
*scientific basis, diagnosis, staging
Myelosuppression and Overview of Growth Factors
Danielle Roman, Clinical Pharmacist Specialist, BCOP
*treatment/symptom management
Cell-Cycle Specific Agents Plant Alkaloids, Antimetabolites, Miscellaneous Agents and Nursing Implications
Mary E. Kern, MSN, RN, OCN, CHSE
*treatment/symptom management
Toxicity Assessments
Marcia Almiron-Wolbert, MSN, RN, OCN
*treatment/symptom management
Additional Information
| Attachment | Size |
|---|---|
 AHNB21-207 (2-26) ACT SOP Manual 2026_final (1).pdf | 2.22 MB |
| AHNB21-206 (2-26)_ACT book_final.pdf | 21.74 MB |
| AHNB21-208 (2-26) ACT Workbook Template_final.pdf | 3.62 MB |
Accreditation: Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material activity for a maximum of 5.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Allegheny Health Network is approved as a provider for nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
Available Credit
- 5.25 AMA PRA Category 1 Credit™
- 5.25 Attendance
- 5.25 NCPD
AHN West Penn Hospital is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Nurses completing the entire activity and the evaluation tool will be awarded a maximum of 5.25 contact hours of nursing continuing professional development (NCPD).